Oliver S. Chow
YOU?
Author Swipe
View article: Sublobar Resection Is the Preferred Surgical Strategy for Clinical Stage IA Lung Cancers Presenting as Sub-solid Nodule
Sublobar Resection Is the Preferred Surgical Strategy for Clinical Stage IA Lung Cancers Presenting as Sub-solid Nodule Open
View article: No down-side to starting durvalumab immediately after chemoradiation for unresectable stage III non-small cell lung cancer—some answers but more questions
No down-side to starting durvalumab immediately after chemoradiation for unresectable stage III non-small cell lung cancer—some answers but more questions Open
View article: Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) Database
Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) Database Open
Objective: Adenoid cystic carcinoma (ACC) is a rare malignant tumor that mainly arises in the head and neck area. We aimed to compare the long-term survival of patients with ACC based on their geographic regions within the United States us…
View article: Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer
Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer Open
Patients with inferior performance status or lower baseline pulmonary function are more likely to receive wedge resection for clinical stage IA NSCLC ≤2 cm in size. For these small tumors, lobectomy, segmentectomy, and wedge resection prov…
View article: P1.26-05 Sublobar Resection is Equivalent to Lobectomy for Stage IA Adenocarcinoma Presenting as Subsolid Nodule
P1.26-05 Sublobar Resection is Equivalent to Lobectomy for Stage IA Adenocarcinoma Presenting as Subsolid Nodule Open
View article: Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer Open
View article: Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report
Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report Open
View article: KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix Open
Somatic mutations in the KRAS oncogene are associated with poor outcomes in locally advanced rectal cancer but the underlying biologic mechanisms are not fully understood. We profiled mRNA in 76 locally advanced rectal adenocarcinomas from…
View article: P37.04 EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis
P37.04 EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis Open
View article: P08.04 Progress in Early Stage Lung Cancer Among Economically Disadvantaged Patients
P08.04 Progress in Early Stage Lung Cancer Among Economically Disadvantaged Patients Open
View article: Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy Open
A WW strategy for select rectal cancer patients who had a clinical complete response after neoadjuvant therapy resulted in excellent rectal preservation and pelvic tumor control; however, in the WW group, worse survival was noted along wit…
View article: Lymph node yield in right colectomy for cancer: a comparison of open, laparoscopic and robotic approaches
Lymph node yield in right colectomy for cancer: a comparison of open, laparoscopic and robotic approaches Open
Aim Studies have demonstrated a relationship between lymph node ( LN ) yield and survival after colectomy for cancer. The impact of surgical technique on LN yield has not been well explored. Method This is a retrospective study of right co…
View article: Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients Open
View article: KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy Open
View article: Integrated genomic profiling identifies micro<scp>RNA</scp>‐92a regulation of <scp>IQGAP</scp>2 in locally advanced rectal cancer
Integrated genomic profiling identifies micro<span>RNA</span>‐92a regulation of <span>IQGAP</span>2 in locally advanced rectal cancer Open
Locally advanced rectal cancer (LARC) is treated with chemoradiation prior to surgical excision, leaving residual tumors altered or completely absent. Integrating layers of genomic profiling might identify regulatory pathways relevant to r…
View article: Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial Open
View article: Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management Open
View article: Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial Open